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Introduction
Recovery after total knee or hip replacement surgery 
is influenced by intrinsic patient factors including pre-
operative mental health (Lingard et al 2004), general health 
status (Long et al 2005), age (Nilsdotter et al 2003, Roder 
et al 2003), gender (Roder et al 2003) and the number of 
medical co-morbidities (Fortin et al 2002, Lingard et al 
2004). Self-reported pre-operative pain and function predict 
pain and function 6 to 42 months post-surgery (Fortin et al 
2002, Fortin et al 1999, Lingard et al 2004, Nilsdotter et al 
2003); and age and gender affect self–reported ambulatory 
capacity up to 15 years post-hip replacement (Roder et al 
2003). In terms of measured physical performance, pre-
operative knee stiffness is a strong predictor of stiffness up 
to three years post-knee replacement (Gandhi et al 2006, 
Ritter et al 2003), and pre-operative quadriceps strength 
predicts improvement in Timed Up and Go and stair 
climbing one year post-knee replacment (Mizner et al 2005). 
Socioeconomic factors also predict recovery, with low-level 
educational attainment associated with poorer recovery of 
function (Bischoff-Ferrari et al 2004, Fortin et al 2002).
Other factors observed to influence recovery include the 
presence of severe other joint disease and obesity. Multijoint 
dysfunction is common amongst joint replacement recipients 
(Hawker et al 1998, Roder et al 2003), and the 10-year risk 
of progression to a contralateral knee replacement following 
unilateral knee replacement is high (37–63% according to 
McMahon and Block 2003); thus, it is not surprising that 
other joint disease (notably, lumbar or lower limb) can 
impede recovery. Patients with other joint disease or co-
morbidity that impairs mobility, report lower ambulatory 
capacity and function following hip replacement than those 
who do not (Roder et al 2003). Similarly, other joint disease 
predicts self-reported function following primary knee 
(Hawker et al 1998) and hip replacement (Bischoff-Ferrari 
et al 2004, Nilsdotter et al 2003). In fact, the aforementioned 
finding that pre-operative function predicts post-operative 
function, may be explained partly by the presence of other 
joint disease and not just the pre-operative dysfunction of 
the operated joint.
The effect of obesity on recovery is less straightforward. 
Similar relative improvements in self-reported pain and 
function in obese and non-obese patients have been 
observed (Spicer et al 2001, Stickles et al 2001). Others have 
demonstrated that self-reported function is poorer in obese 
patients post-hip (Bischoff-Ferrari et al 2004, Moran et al 
2005, Roder et al 2003) and post-knee replacement (Foran 
et al 2004, Hawker et al 1998), and poorer in obese women 
after hip replacement compared to obese men (Lubbeke et 
al 2007). Similarly, the impact of body mass on prosthesis 
longevity is also unclear. Some investigators report worse 
prosthesis durability in hip replacement patients with body 
mass greater than 80 kg (Surin and Sundholm 1983) and 
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in morbidly-obese knee replacement patients (Foran et al 
2004), whilst others have observed no differences in relation 
to obesity (Hawker et al 1998, Spicer et al 2001).
This study prospectively evaluates the multidimensional 
effect of severe other joint disease and obesity on outcomes 
following joint replacement surgery. Such information is 
useful for informing patients about realistic expectations 
from surgery and in guiding clinicians in their development 
of appropriate rehabilitation goals, strategies and 
benchmarking. The research questions were:
Are either severe other joint disease or obesity 1. 
associated with a slower rate of recovery after total hip 
or knee replacement surgery?
Are they associated with less absolute recovery up to 2. 
one year post-surgery?
Method
Design
A prospective, observational study was undertaken in a 
joint replacement centre within a metropolitan hospital. 
Measurements were conducted one to two weeks pre-
surgery at a pre-admission clinic. Subsequent measurements 
were conducted at 2, 6, 12, 26 and 52 weeks post-surgery. 
Assessor-blinding to the presence of obesity or severe other 
joint disease was not possible. Assessments were performed 
by the same two observers, however, who were trained in 
the conduct of each test and who followed a standardised 
pro forma. Interpreters were used when required. Ethical 
approval for the study was provided by the Sydney South 
West Area Health Service Human Ethics Committee. 
Patients provided written informed consent.
Participants
Consecutive patients undergoing primary unilateral knee 
or hip replacement surgery across 2003 and 2004 were 
approached. Exclusion criteria included: surgical procedures 
additional to the planned replacement; a second replacement 
planned within one year of the first; dementia; and residing 
more than 50 km from the hospital. Demographic and 
surgical variables – and later, post-operative complications 
– were obtained via interview and chart review.
Outcome measuress
Pain in the operated joint was measured using a 10-cm 
visual analogue scale. Mobility was measured using the 
15-m Walk Test, the Timed Up and Go Test (Mizner et 
al 2005), and walking aid utilisation at one year. Global 
improvement in the operated joint was measured using a 
5-level scale: much better; better; same; worse; and much 
worse.
A subset of participants (those able to read English) completed 
self-administered questionnaires: the Western Ontario and 
McMaster Universities (WOMAC) Osteoarthritis Index 
(Bellamy et al 1988), and the Short Form-36 (SF-36 version 
2) (Ware 2000) pre-operatively, and at 26 and 52 weeks. 
Research
Figure 1. Flow of participants through the study. Two patients 
had another joint replaced after nine months. Their nine-month 
data were extrapolated to their 12-month review. TKR = total knee 
replacement, THR = total hip replacement.
Surgical patients (n = 160, TKR = 96, THR = 64)
Presented to pre-admission clinic (n = 125, TKR = 70, THR = 55)
Consented to long-term follow-up (n=122, TKR = 67, THR = 55)
Withdrew after surgery (n = 1)
Transferred to another hospital (n = 1)
Withdrew after 2 weeks (n = 1)
Not contactable (n = 16)
Moved interstate (n = 1)
Another joint replaced (n = 1)
Withdrew after 26 weeks (n = 2)
Participants remaining at 6 weeks (n = 119)
Participants remaining at 26 weeks (n = 101)
Participants remaining at 52 weeks (n = 99, TKR = 55, THR = 44)
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Both tools have face, content, and construct validity, 
demonstrate good reliability, and are responsive to small 
changes in small samples (Bellamy et al 1988, Ware 2000). 
The WOMAC comprises three subscales: Pain (five items), 
Stiffness (two items) and Function (Difficulty) (17 items), 
with each item in the subscales scored on a 0–4 Likert rating 
scale. Each subscale is summed (maximum total of 20 for 
Pain, 8 for Stiffness, and 68 for Function); a lower score 
indicating better status. Improvements within this scale are 
intended to reflect specific joint improvement since the items 
pertain to specific joint behaviour. The SF-36 is a generic 
health-related quality of life scale that measures more 
global health constructs. It has eight subscales (domains) 
which reflect dimensions of health: Physical Function; Role 
Function–Physical; Bodily Pain; General Health; Vitality; 
Social Functioning; Role Function–Emotional; and Mental 
Health. Each domain score is transformed to a 0–100 scale, 
in this case, using the algorithm developed for Australian 
populations (Australian Bureau of Statistics 1995); higher 
scores indicate better status.
Data analysis
A sample of 125 patients, allowing for a 20% loss to follow-
up, provided an 80% chance of detecting a small main effect 
(time) (0.28 SD) and a moderate between-group effect (0.57 
SD) in any variable. The cohort was stratified according to 
the presence of severe other joint disease both pre-operatively 
and at one year post-surgery using an adapted version of the 
Charnley Classification for co-morbidity (Charnley 1972). 
Patients reporting that their mobility was not held back by 
severe other joint disease were classified as Charnley Class 
A and denoted as the Non-Severe Group. Patients reporting 
their mobility was impeded by severe other joint disease 
were classified as Charnley Class B (contralateral joint) 
or C (remote joint), and collectively denoted as the Severe 
Group. Patients were also stratified according to body mass 
index (BMI): obese = BMI ≥ 30; non-obese = BMI < 30.
Between-group differences in demographic and surgical 
profiles were analysed using independent t-tests or the 
χ2 Test of Independence. Between-group differences in 
recovery rates were analysed for continuous variables (pain, 
Table 1. Demographic, surgical, discharge, and major complication characteristics of the participants.
Severe other 
joint disease 
n= 42
No severe 
other joint 
disease
n = 57
Obese 
 
n = 50
Non-obese 
 
n = 49
Demographic
Age (years), mean (SD) 68.7 (8.8) 66.4 (8.8) 67.3 (1.1) 67.4 (1.4)
Body mass index (kg/m2), mean (SD)
Obese, n (%)
32.5 (5.8)
26 (62)
29.5 (5.5)
24 (42)
35.2 (4.1) 26.2 (3.0)
Female gender, n (%) 27 (64) 29 (51) 32 (64) 24 (49)
Osteoarthritis, n (%) 34 (81) 49 (86) 42 (84) 41 (84)
Total knee replacement, n (%) 20 (48) 35 (61) 32 (64) 23 (47)
Co-morbidities, n (%)
   3 or more significant conditions
   Cardiac disease
   Respiratory disease
   Peripheral vascular disease
   Types 1 or 2 diabetes
   Hypertension 
18 (43)
8 (19)
12 (29)
6 (14)
13 (31)
29 (69)
14 (25)
15 (26)
11 (19)
6 (11)
10 (18)
32 (56)
2 (40)
12 (24)
15 (30)
4 (8)
17 (34)
35 (70)
12 (24)
11 (22)
8 (16)
8 (16)
6 (12)
26 (53)
Pre-operative haemoglobin (g/l), mean (SD) 138.0 (11.4) 140.1 (12.4) 138.8 (11.6) 141.5 (13.1)
Surgical
   Surgical time (min), mean (SD) 126.3 (27.7) 127.5 (25.9) 125.8 (24.1) 130.5 (30.9)
   Donor transfusion, n (%) 20 (47) 24 (43) 18 (36) 27 (55)
   Tourniquet time (knees) (min), mean (SD) 99.3 (21.8) 101.1 (19.8) 99.6 (20.8) 101.5 (20.1)
   Cement fixation, n (%) 21 (50) 34 (61) 24 (48) 26 (53)
Discharge
   Transfer to inpatient rehabilitation, n (%) 3 (7) 7 (12) 4 (8) 6 (12)
   Length of stay (days), median (range) 5.0 (3–27) 5.0 (3–24) 5 (3–27) 5.0 (3–24)
Major complications, n
   Dislocation (hip) 3 2 4 1
   Deep surgical site infection 1 1 1 1
   Venous thromboembolism 1 4 2 3
   Neuropraxia 1 0 0 1
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mobility, WOMAC and SF-36) using repeated measures 
planned orthogonal contrasts. Mean differences (95% CI) 
at 52 weeks were used to determine differences in absolute 
recovery in the continuous variables. Odds ratios (95% 
CI) at one year were used to determine differences for the 
chance of walking aid use and global improvement. For all 
analyses, p < 0.05 was deemed significant.
Results
Flow of participants through the study
Figure 1 details flow of participants through the study. Of 
the 122 patients who consented to follow-up, 99 (81%) were 
available for follow-up at one year (Table 1). Of these 99, 57 
(58%) had no severe other joint disease (Non-severe Group), 
and 42 (42%) had severe other joint disease (Severe Group), 
25 of whom were waitlisted for replacement surgery of 
another joint at one year. Of the 99, 50 (51%) were obese, 55 
(56%) (including 32 females) had a total knee replacement, 
had an average age of 70 years (SD 8), and an average BMI 
of 32 (SD 6); 44 (44%) (including 24 females) had a total 
hip replacement, were aged 65 years old (SD 9), and had a 
BMI of 30 (SD 5).
Table 1 summarises the demographic, surgical, discharge, 
and complication characteristics of the participants. 
Characteristics were essentially similar across groups, 
however, participants with severe other joint disease had 
a significantly (p =  0.01) higher body mass index then 
those without severe other joint disease. Also, participants 
who were obese had a significantly (p < 0.01) higher body 
mass index then those who were not obese, and a higher 
incidence of diabetes (p < 0.01). Cement fixation, patella 
resurfacing and prosthesis type were clinician-dependent 
(n = 6 surgeons), as was the type of anaesthesia (n = 4 
anaesthetists). No patients died, had revision surgery, or 
underwent manipulation under anaesthetic in the first 
post-operative year. Patients received daily physiotherapy 
until discharge, and prophylaxis for thromboembolism 
and infection. Referral to ongoing physiotherapy was 
routine practice, with 90% of patients attending outpatient 
programs.
Effect of severe other joint disease
Severe and non-severe group data and between-group 
differences at every measurement occasion are presented 
in Table 2, while Table 3 presents results for outcomes 
measured pre-surgery, Week 26, and Week 52 post-surgery. 
Recovery patterns are presented in Figures 2–5 (see 
eAddenda for Figures 2–5).
Timed mobility improved after the first 2 post-operative 
weeks. In terms of rate of recovery, the severe group 
recovered more slowly than the non-severe group in the 
15-m Walk Test (p =  0.005). Rate of recovery was similar 
between the groups in pain and mobility (Timed Up and 
Go Test). Of the English-speaking subgroup, the severe 
group recovered more slowly than the non-severe group in 
2 of the 3 domains of the WOMAC (stiffness p =  0.03 and 
function p =  0.02) and 2 of the 8 domains of the SF-36 
(physical function p =  0.01, and general health p =  0.01). 
Detailed statistical results are presented in Tables 3 and 4 
(see eAddenda for Tables 3 and 4).
In terms of absolute recovery at 52 weeks, the severe group 
walked 0.27 m/s (95% CI 0.15 to 0.40) more slowly on the 
15-m Walk Test and took 4.0 s (95% CI 2.3 to 5.8) longer on 
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the Timed Up and Go Test than the non-severe group. There 
was a 6.8 greater chance (95% CI 2.8 to 16.5) that the severe 
group would be using a walking aid since 27 (64%) of them 
did compared with 12 (21%) of the non-severe group. On the 
other hand, pain was no worse (mean difference 0.1 cm, 95% 
CI –1.0 to 0.8) and global improvement was similar (OR 0.7, 
95% CI 0.1 to 5.4) in the severe group compared with the 
non-severe group. Of the English-speaking subgroup, the 
severe group scored worse on the function domain of the 
WOMAC (mean difference 12.2 out of 68, 95% CI 3.5 to 
20.9) and the physical function (mean difference 23%, 95% 
CI 10 to 37), role physical (mean difference 26%, 95% CI 11 
to 42), bodily pain (mean difference 20%, 95% CI 4 to 36), 
vitality (mean difference 14%, 95% CI 1 to 27), and social 
function (mean difference 16%, 95% CI 1 to 31) domains of 
the SF-36 compared with the non-severe group.
Effect of obesity
Obese and non-obese group data and between-group 
differences at every measurement occasion are presented 
in Table 6, while Table 7 presents results for outcomes 
measured pre-surgery, Week 26, and Week 52 post-surgery. 
Recovery patterns are presented in Figures 2–5 (see 
eAddenda for Figures 2–5).
Timed mobility improved after the first 2 post-operative 
weeks. In terms of rate of recovery, the obese and non-
obese groups were similar in mobility (15-m Walk Test and 
Timed Up and Go Test), and pain, except after 26 weeks 
where the obese group continued to report improvement 
in pain while the non-obese group did not (p = 0.003). 
Of the English-speaking subgroup, the rate of recovery 
was similar between the groups for WOMAC and SF-36. 
Detailed statistical results are presented in Tables 4 and 5 
(see eAddenda for Tables 4 and 5).
In terms of absolute recovery at 52 weeks, the obese group 
walked 0.23 m/s (95% CI 0.10 to 0.36) more slowly on the 
15-m Walk Test and took 3.1 s (95% CI 1.3 to 4.9) longer on 
the Timed Up and Go Test than the non-obese group. There 
was a 2.8 greater chance (95% CI 1.2 to 6.4) that the obese 
group would be using a walking aid since 25 (50%) of them 
did compared with 13 (27%) of the non-obese group. On 
the other hand, pain was no worse (mean difference 0.5 cm, 
95% CI 0.4 to 1.4) and global improvement was similar (OR 
0.33, 95% CI 0.03 to 3.25) in the obese group compared with 
the non-obese group. Of the English-speaking subgroup, 
the obese group scored worse on the pain (mean difference 
2.5 out of 20, 95% CI 0.2 to 4.9) and the function (mean 
difference 9.6 out of 68, 95% CI 1.0 to 18.2) domains of the 
WOMAC, and the physical function (mean difference 18%, 
95% CI 5 to 32), bodily pain (mean difference 17%, 95% 
CI 1 to 33), and the social function (mean difference 17%, 
95% CI 3 to 32) domains of the SF-36 compared with the 
non-obese group.
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Table 3. Mean (SD) of severe and non-severe groups and mean (95% CI) difference between groups for outcomes 
measured pre-surgery, Week 26 and Week 52 post-surgery.
Outcome Groups Difference between groups
Pre Wk 26 Wk 52 Pre Wk 26 Wk 52
Severe Non-
severe
Severe Non-
severe
Severe Non-
severe
Severe minus non-severe
WOMAC 
n = 52
Pain 
(0 to 20)
12.7 
(2.2)
12.2 
(3.4)
6.8 
(4.2)
4.1 
(4.4)
5.6 
(4.7)
3.3 
(4.0)
0.5 
(–1.3 to 2.2)
2.8 
(0.3 to 5.3)
2.3 
(–0.1 to 4.8)
Stiffness 
(0 to 8)
5.1 
(1.6)
5.4 
(1.5)
2.9 
(2.0)
2.8 
(1.7)
2.9 
(1.8)
1.9 
(1.7)
0.3 
(–0.6 to 1.2)
–0.2 
(–1.2 to 0.9)
–1.0 
(–2.0 to 0.0)
Function 
(0 to 68)
44.7 
(9.0)
41.4 
(11.1)
26.4 
(15.3)
17.6 
(14.1)
26.1 
(16.8)
13.9 
(2.4)
3.3 
(–2.7 to 9.3)
8.8 
(0.4 to 17.2)
12.2 
(3.5 to 20.9)
SF-36 (0 to 100)  
n = 53
Physical function 18 
(19)
24 
(22)
34 
(20)
58 
(20)
37 
(24)
60 
(24)
–5.7 
(–18 to 6)
–24 
(–35 to –12)
–23 
(–37 to –10)
Role physical 26 
(22)
34 
(25)
37 
(23)
59 
(27)
42 
(29)
68 
(26)
–8.0 
(–21 to 6)
–22 
(–36 to –7)
–26 
(–42 to –11)
Bodily pain 24 
(15)
31 
(19)
48 
(23)
60 
(25)
49 
(26)
69 
(29)
–7 
(–17 to 3)
–12 
(–26 to 2)
–20 
(–36 to –4)
Role emotional 55 
(34)
53 
(31)
57 
(30)
75 
(27)
64 
(31)
79 
(23)
2 
(–16 to 20)
–18 
(–34 to –2)
–15 
(–30 to 0)
General health 61 
(17)
55 
(23)
58 
(26)
65 
(20)
59 
(23)
66 
(21)
5 
(–7 to 17)
–7 
(–20 to 6)
–7 
(–19 to 5)
Vitality 42  
(22)
42 
(18)
45 
(22)
54 
(20)
44 
(26)
58 
(21)
–1 
(–11 to 11)
–9 
(–21 to 3)
–14 
(–27 to –1)
Social function 51 
(28)
51 
(28)
64 
(32)
75 
(27)
63 
(28)
79 
(26)
1 
(–15 to 16)
–12 
(–28 to 5)
–16 
(–31 to –1)
Mental health 66 
(19)
64 
(21)
71 
(19)
73 
(22)
74 
(15)
75 
(22)
2 
(–10 to 13)
–2 
(–14 to 10)
–1 
(–13 to 10)
WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index, SF-36 = Short Form 36 version
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Discussion
Primary unilateral total knee or hip replacement conferred 
significant improvements in many outcomes. The 
improvements in the SF-36 domains were such that the scores 
approached population norms (ABS 1995) (more so for non-
obese patients and those without severe other joint disease), 
and this observation accords with other local (Bachmeier et 
al 2001, March et al 1999) and international studies (Fortin 
et al 1999, Fortin et al 2002, Stickles et al 2001) reporting 
outcomes one to two years post joint replacement. The 
large improvements observed in WOMAC scores are also 
typical (Bachmeier et al 2001, Kennedy et al 2006, Stickles 
et al 2001), as are the improvements in operated joint pain 
(Roder et al 2003), and the finding that, for many outcomes, 
most improvements occurred within the first six months 
post-surgery. The stratification of patients according to the 
presence of severe other joint disease or obesity was useful 
as it revealed that the presence of these impairments was 
associated with poorer rates of recovery and/or absolute 
recovery for several outcomes at one year.
Poorer WOMAC scores up to seven years post-surgery in 
patients with severe other joint disease have been reported 
(Bischoff-Ferrari et al 2004, Hawker et al 1998, Nilsdotter et 
al 2003, Stickles et al 2001). Here, WOMAC function scores 
were worse overall in such patients; close inspection of the 
data indicating this was mainly explained by differences 
after surgery. Why index (operated) joint function was worse 
post-operatively in patients with severe other joint disease is 
intriguing and may have several explanations. The presence 
of other joint disease may compromise recovery of function 
in the operated joint, and thus may explain post-operative 
joint-specific differences in function. Additionally, patients 
with severe multijoint dysfunction may have greater index 
joint dysfunction pre-operatively, although this explanation 
is not supported by the current data since mean differences at 
baseline in WOMAC scores were not significantly different 
(Table 3). Alternatively, it is possible when interpreting the 
WOMAC, and despite instruction to do so, that patients may 
be unable to totally isolate the effects of the operated joint 
from the debilitating effects of other dysfunctional joints.
The differential improvements observed here in many of the 
SF-36 domains based on the presence of severe other joint 
disease – and the poorer scores overall in some domains 
– were anticipated given that the SF-36 encompasses other 
joints and total bodily pain. Obesity was also associated 
with poorer scores in several domains, concurring with the 
findings of Stickles et al (2001). Other investigators have 
also observed poorer function in obese patients using the 
Harris Hip Score (Moran et al 2005), Knee Society Score 
(Spicer et al 2001), and WOMAC (Hawker et al 1998, 
Stickles et al 2001), but all conclude that obese patients 
are able to gain considerable improvements from surgery, 
and so joint replacement remains an appropriate treatment 
option. This conclusion is corroborated by the current study 
since, independent of obesity, patients perceived major 
global improvements in their joint behaviour.
Though obesity or severe other joint disease did not preclude 
improvement in walk speed, stratification of the cohort 
revealed that patients with such co-morbidities remained 
slower than age-matched norms (1.33–1.59 m/s); 8 sec for 
Timed Up and Go Test) (Steffen et al 2002). The slower 
mobility associated with severe other joint disease and/or 
obesity is clinically relevant as reliance on walking aids 
was greater, and function (assessed by WOMAC and SF-36) 
appeared more compromised in these patients.
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Stratification versus multiple regression 
analyses
It was not possible in the one study to also address the effect 
on outcomes of extrinsic influences such as surgeon volume, 
the annual volume of surgery performed by a facility, 
prosthesis factors, and a multitude of clinical practices 
extending from the pre-operative period to the downstream 
post-discharge period. Whilst it is not yet possible to 
assemble all the factors into a hierarchy of importance, 
the current study is important as it uniquely quantifies the 
impact of time, severe other joint disease, and obesity on a 
range of clinical and patient-centred outcomes.
A primary focus here was examination of the influence of 
specific co-morbidities on recovery at various time points. 
Stratification of the cohort by co-morbidity and the use of 
repeated measures analyses provided a robust and clinically 
useful way to do this. Multiple regression analysis may be 
viewed as a stronger approach for identifying important 
predictor variables owing to its simultaneous consideration 
of confounding factors, but for examining recovery across 
various time points, it is not the preferred approach. For 
completeness, however, results from post-hoc multiple 
regression analyses that identified predictors of outcomes 
at one year are provided in Appendix 1 (see eAddenda 
for Appendix 1). The regressions (that also included age, 
gender, surgery type and number of co-morbidities as 
predictor variables) were consistent with the results from 
the contrast analyses. That is, the presence of severe other 
joint disease in particular appears to be a most important 
predictive factor for several outcomes.
Implications for rehabilitation
That obese patients or those with severe other joint disease 
still experience some degree of dependence in function 
one year post-surgery has implications for rehabilitation. 
Rehabilitation offered to patients presenting within this time 
period should accommodate differences in physical and 
function based on the co-morbidities described. Intuitively, 
hydrotherapy may be more appropriate for some in view of 
its capacity to unload immersed joints; and since obesity is 
potentially modifiable it is recommended that such patients 
be referred for weight management. Finally, rehabilitation 
programs in Australia following knee replacement cease 
six to eight weeks after surgery (Naylor et al 2006). This 
would appear to be before recovery in many domains has 
stabilised, and thus the available rehabilitation programs 
may be of insufficient duration.
eAddenda: Figures 2–5, Tables 4 and 5, and Appendix 1 
available at www.physiotherapy.asn.au
Naylor et al: Factors associated with recovery after joint replacement
Table 7. Mean (SD) of obese and non-obese and mean (95% CI) difference between groups for outcomes measured  
pre-surgery, Week 26 and Week 52 post-surgery.
Outcome Groups Difference between groups
Pre Wk 26 Wk 52 Pre Wk 26 Wk 52
Obese Non-
obese
Obese Non-
obese
Obese Non-
obese
Obese minus non-obese
WOMAC 
n = 52
Pain 
(0 to 20)
12.7 
(2.3)
12.1 
(3.5)
6.3 
(4.8)
4.0 
(4.0)
5.5 
(5.0)
2.9 
(3.2)
0.6 
(–1.1 to 2.3)
2.3 
(–0.1 to 4.8)
2.5 
(0.2 to 4.9)
Stiffness 
(0 to 8)
5.4 
(1.6)
5.1 
(1.5)
3.1 
(2.1)
2.6 
(1.5)
2.8 
(2.0)
1.9 
(1.5)
–0.3 
(–1.2 to 0.6)
–0.5 
(–1.5 to 0.6)
–0.9 
(–1.8 to 0.1)
Function 
(0 to 68)
44.6 
(8.3)
40.7 
(11.9)
26.2 
(16.6)
15.9 
(11.7)
23.3 
(17.2)
13.7 
(13.5)
3.9 
(–1.8 to 9.6)
10.3 
(2.3 to 18.2)
9.6 
(1 to 18.2)
SF-36 (0 to 100) 
n = 53
Physical function 14 
(17)
28 
(23)
37 
(21)
60 
(19)
42 
(23)
60 
(26)
–14 
(–25 to – 3)
–23 
(–34 to –12)
–18 
(–32 to –5)
Role physical 23 
(16)
38 
(28)
39 
(22)
61 
(28)
51 
(29)
65 
(29)
–15 
(–28 to –3)
–22 
(–36 to –8)
–14 
(–30 to 2)
Bodily pain 22 
(12)
35 
(20)
49 
(21)
62 
(27)
53 
(29)
70 
(28)
–12 
(–22 to –3)
–13 
(–27 to 0)
–17 
(–33 to –1)
Role emotional 48 
(31)
60 
(32)
61 
(28)
74 
(30)
66 
(31)
81 
(21)
–11 
(–29 to 6)
–14 
(–29 to 3)
–15 
(–29 to 0)
General health 50 
(20)
64 
(20)
56 
(24)
69 
(20)
59 
(25)
67 
(18)
–14 
(–25 to –3)
–13 
(–25 to –1)
–8 
(–20 to 4 )
Vitality 37 
(18)
47 
(20)
45 
(18)
56 
(23)
50 
(23)
56 
(24)
–10 
(–20 to 1)
–11 
(–23 to 0)
–7 
(–19 to 6)
Social function 41 
(21)
61 
(31)
61 
(27)
81 
(29)
64 
(29)
82 
(23)
–20 
(–34 to –5)
–20 
(–36 to –5)
–17 
(–32 to –3)
Mental health 62 
(15)
68 
(23)
67 
(20)
78 
(20)
70 
(22)
79 
(17)
–7 
( –18 to 4)
–11 
(–23 to 0)
–9 
(–19 to 2)
WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index, SF-36 = Short Form 36 version
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